Phreesia, Inc. (PHR)

NYSE: PHR · IEX Real-Time Price · USD
31.09
-1.14 (-3.54%)
Mar 28, 2023, 4:00 PM EDT - Market closed
-3.54%
Market Cap 1.66B
Revenue (ttm) 280.91M
Net Income (ttm) -176.15M
Shares Out 53.36M
EPS (ttm) -3.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 369,520
Open 31.95
Previous Close 32.23
Day's Range 30.96 - 32.54
52-Week Range 13.19 - 40.00
Beta 0.65
Analysts Buy
Price Target 39.49 (+27.02%)
Earnings Date Mar 22, 2023

About PHR

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and ... [Read more]

Sector Healthcare
IPO Date Jul 18, 2019
Employees 1,701
Stock Exchange NYSE
Ticker Symbol PHR
Full Company Profile

Financial Performance

In 2023, Phreesia's revenue was $280.91 million, an increase of 31.74% compared to the previous year's $213.23 million. Losses were -$176.15 million, 49.1% more than in 2022.

Financial Statements

Analyst Forecast

According to 19 analysts, the average rating for PHR stock is "Buy." The 12-month stock price forecast is $39.49, which is an increase of 27.02% from the latest price.

Price Target
$39.49
(27.02% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates

Phreesia (PHR) delivered earnings and revenue surprises of 7.69% and 2.56%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

6 days ago - Zacks Investment Research

Phreesia Announces Fourth Quarter Fiscal 2023 Results

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2023. "The...

6 days ago - Business Wire

Phreesia Announces Chief Financial Officer Transition

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR), a leader in patient intake, outreach and activation, today announced the appointment of Balaji Gandhi as Phreesia's Chief Financial Offic...

6 days ago - Business Wire

Phreesia Named as One of the Achievers 50 Most Engaged Workplaces® of 2023

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been named as one of the 2023 Achievers 50 Most Engaged Workplaces®.

1 week ago - Business Wire

Phreesia's Alexandra Beneville Named One of MM+M's ‘Women to Watch' for 2023

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announces that MM+M has named Alexandra Beneville, Vice President, Life Sciences Content Strategy, to its Women to Watch class of 2023.

1 week ago - Business Wire

Phreesia's Dan Nathan Named as a Top Software CTO of 2023

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is proud to announce that Dan Nathan, the company's Chief Technology Officer, has been named as one of the Top 25 Software CTOs of 2023.

1 week ago - Business Wire

What Makes Phreesia (PHR) a New Buy Stock

Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 month ago - Zacks Investment Research

Phreesia (PHR) Soars 6.1%: Is Further Upside Left in the Stock?

Phreesia (PHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength do...

1 month ago - Zacks Investment Research

Phreesia Sets Release Date for Fiscal Fourth Quarter 2023 Results

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal fourth quarter 2023 financial results after the close of market trading on ...

1 month ago - Business Wire

Phreesia Included in 2023 Bloomberg Gender-Equality Index for the Third Consecutive Year

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, is joining 483 other companies as a member of the 2023 Bloomberg Gender-Equality Index (GEI). This r...

2 months ago - Business Wire

Phreesia and the Ad Council Partnership Drives Strong Engagement Across 3 Public Health Campaigns

WILMINGTON, Del. & NEW YORK--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, along with the Ad Council, a nonprofit organization at the forefront of driving change th...

2 months ago - Business Wire

Phreesia Life Sciences Named One of MM+M's “Best Places to Work 2022”

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that for the second year in a row, the healthcare marketing industry trade pu...

2 months ago - Business Wire

Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates

Phreesia (PHR) delivered earnings and revenue surprises of 13.64% and 2.73%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Phreesia Announces Third Quarter Fiscal 2023 Results

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the third quarter ended October 31, 2022.

3 months ago - Business Wire

Phreesia's Sara DiNardo Selected as a Top Woman Leader in SaaS

WILIMINGTON, Del.--(BUSINESS WIRE)--Phreesia is proud to announce that Sara DiNardo, the company's Vice President of Client Solutions, has been named to The Software Report's list of the Top 50 Wome...

4 months ago - Business Wire

Phreesia Sets Release Date for Fiscal Third Quarter 2023 Results

RALEIGH, N.C.

5 months ago - Business Wire

Can Phreesia (PHR) Climb 26% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 25.7% in Phreesia (PHR). While the effectiveness of this highly sought-after metric is questionable, the positi...

6 months ago - Zacks Investment Research

Phreesia Names Alexandra Beneville Vice President of Life Sciences Content Strategy

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has named Alexandra Beneville as Vice President of Life Sciences Content Strategy. Beneville officiall...

6 months ago - Business Wire

Phreesia's Zeeshan Butt Named to NQF's MAP Clinician Workgroup

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is proud to announce that Zeeshan Butt, PhD, a Director of Clinical Content, has been selected to serve a three-year term as a member of the National Qualit...

6 months ago - Business Wire

Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates

Phreesia (PHR) delivered earnings and revenue surprises of 10.10% and 3.04%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

Phreesia Announces Fiscal Second Quarter 2023 Results

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2022. "I am extremely proud of o...

7 months ago - Business Wire

Phreesia Sets Release Date for Fiscal Second Quarter 2023 Results

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal second quarter 2023 financial results after the close of market trading on Wedne...

8 months ago - Business Wire

Phreesia Named to The Software Report's “Top 100 Software Companies of 2022”

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that it has been named to The Software Report's list of “The Top 100 Software Companies of 2022.” The annual award recognizes the best c...

9 months ago - Business Wire

Here's Why Phreesia (PHR) Is a Great 'Buy the Bottom' Stock Now

After losing some value lately, a hammer chart pattern has been formed for Phreesia (PHR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisio...

9 months ago - Zacks Investment Research

Wall Street Analysts See a 38% Upside in Phreesia (PHR): Can the Stock Really Move This High?

The mean of analysts' price targets for Phreesia (PHR) points to a 37.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

9 months ago - Zacks Investment Research